Verve Therapeutics, Inc.
VERVCIK 0001840574 · Every Form 4 filed by insiders at this issuer.
Filings
6
Latest Feb 16, 2024
Unique insiders
6
Showing
6 of 6
Page 1
Top insiders
Most active reporters at Verve Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Ashe Andrew D. | Officer | 1 |
| Bellinger Andrew | Officer | 1 |
| Dorval Allison | Officer | 1 |
| Fiedorek Fred T. | Officer | 1 |
| Kathiresan Sekar | OfficerDirector | 1 |
| Nickerson Joan | Officer | 1 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 16, 2024 | Bellinger Andrew Chief Scientific Officer | Holdings only | — | — | — | |
| Feb 16, 2024 | Kathiresan Sekar Chief Executive Officer · Director | Holdings only | — | — | — | |
| Feb 16, 2024 | Dorval Allison Chief Financial Officer | Holdings only | — | — | — | |
| Feb 16, 2024 | Ashe Andrew D. See Remarks | Holdings only | — | — | — | |
| Feb 16, 2024 | Nickerson Joan Chief Administrative Officer | Holdings only | — | — | — | |
| Feb 16, 2024 | Fiedorek Fred T. Chief Medical Officer | Holdings only | — | — | — |
Showing 1–6 of 6
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.